IQV IQVIA Holdings Inc
Company Analysis
Latest News
🟢 IQVIA is trading 4.04% up in after-hours trading — no clear company-specific catalyst identified
IQVIA is trading 4.04% up at $289.49 after-hours, with no clear company-specific announcement explaining the move. - Shares closed at $278.25 in the October 22...
IQVIA Gets Higher Price Targets as Stifel Sees 16% Upside
On Wednesday, Stifel Nicolaus raised its IQVIA price target to $303 from $276 and maintained a buy rating. The firm cited an improving market backdrop, IQVIA’s...
🟢 IQVIA is trading 4.15% up in pre-market with immediate catalyst unclear
IQVIA is trading at $271.54, up 4.15% before the October 2, 2026 open, with no clear immediate catalyst identified. - No clearly reported overnight...
🔴 IQVIA is trading 4.3% down in after-hours trading with no clear catalyst identified
IQVIA is trading at $257.29, a change of -4.29%, with no clear company-specific catalyst identified for the September 30 after-hours decline. - IQVIA’s...
IQVIA Swaps Cheap Debt for Expensive Calm — But Can a Higher Interest Bill Really Justify a 7% Rally?
Shares of IQVIA surged 7.3% to $295.08 after the healthcare-data and clinical-trials giant closed a $2 billion senior-notes offering, removing a looming debt...
🟢 IQVIA is trading 7.29% up in pre-market after $2 billion offering extends debt maturities
IQVIA is trading at $295.08 (+7.29%) in pre-market, with its financing update the clearest catalyst as broader markets are modestly higher. - IQVIA completed...
🟢 IQVIA is trading 5% up in pre-market after completing a $2 billion senior-notes offering
IQVIA is trading 5% up at $281.25, with its financing update appearing to support shares after completing a $2.0 billion senior-notes offering on September 23,...
IQVIA Completes $2.0 Billion Senior Notes Offering to Refinance Existing Debt
IQVIA Inc., a wholly owned subsidiary of IQVIA Holdings Inc., has completed the issuance and sale of $2.0 billion in senior unsecured notes. The proceeds are...
🔴 IQVIA is trading 35.1% down in after-hours trading with no credible company-specific catalyst identified
IQVIA is trading at $175.28, down 35.1% in after-hours trading, with no credible September 22, 2026 company-specific catalyst identified. - The quote is...
IQVIA Announces Pricing of $2 Billion Senior Notes Offering to Refinance Debt
IQVIA Holdings Inc. announced the pricing of a $2 billion senior notes offering by its wholly owned subsidiary, IQVIA Inc. The proceeds from this offering are...
🟢 IQVIA is trading 4.3% up in after-hours trading amid planned $2 billion senior-notes offering
IQVIA is trading $267.96 (+4.28%) amid its announcement of a planned $2 billion senior-notes offering due 2034; the financing is not explicitly linked to the...
IQVIA Target Raised to $300 by HSBC, Institutional Interest Grows
HSBC raised its price target for IQVIA Holdings Inc. to $300 from $280. The investment bank maintained its Buy rating on the stock. Institutional investors...
Cantillon Capital Exits $292M IQVIA (IQV) Position
William Von Mueffling's Cantillon Capital Management fully exited its stake in IQVIA Holdings (IQV), selling all 1.71 million shares. The position was valued...
IQVIA Secures $3 Billion Investment From BlackRock and Deutsche Bank
IQVIA Holdings (IQV) attracted major institutional investments from BlackRock Inc. and Deutsche Bank AG. SEC 13F filings reported on August 20, 2026, disclosed...
🟢 IQVIA is trading 4.1% up today as healthcare stocks rallied broadly
IQVIA is trading 4.1% up at $259.51 after healthcare stocks rallied broadly on improving earnings expectations, attractive valuations, and investor rotation...
🟢 IQVIA rises 4.1% — Healthcare Stocks Surge on Strong Earnings Outlook and Investor Rotation
With Healthcare (XLV) up 3.2%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector experienced a significant...
🔴 IQVIA is trading 17.84% down in after-hours trading with no clear catalyst identified
IQVIA is trading $198.52 (-17.84%) after an unexplained August 13, 2026 after-hours decline. • No credible August 13 company-specific catalyst was identified...
🔴 IQVIA is trading 15.1% down in after-hours trading with no clear catalyst identified
IQVIA is trading 15.14% down at $205.15 in after-hours trading after an unexplained August 12, 2026 decline with no clear catalyst identified. - No credible...
🔴 IQVIA is trading 14% down in after-hours trading with no clear catalyst identified
IQVIA is trading 14% down at $209.66 after an unexplained August 11, 2026 after-hours drop from the provided regular-session close of $243.90. - Searches...
🟢 IQVIA is trading 4% up today following multiple analyst upgrades and sector strength
IQVIA is trading 4% up today at $237.42 following a wave of analyst price-target upgrades and broader strength in the healthcare sector. • Argus, Evercore...